100 related articles for article (PubMed ID: 3539326)
1. Effect of differentiation on the expression of a nucleolar antigen with a molecular weight of 145,000 in HL-60 cells.
Freeman JW; Dowell BL; Ochs RL; Ross BE; Busch H
Cancer Res; 1987 Jan; 47(2):586-91. PubMed ID: 3539326
[TBL] [Abstract][Full Text] [Related]
2. Identification and partial characterization of a nucleolar antigen with a molecular weight of 145,000 found in a broad range of human cancers.
Freeman JW; McRorie DK; Busch RK; Gyorkey F; Gyorkey P; Ross BE; Spohn WH; Busch H
Cancer Res; 1986 Jul; 46(7):3593-8. PubMed ID: 3518918
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase.
Freeman JW; Busch RK; Gyorkey F; Gyorkey P; Ross BE; Busch H
Cancer Res; 1988 Mar; 48(5):1244-51. PubMed ID: 3422591
[TBL] [Abstract][Full Text] [Related]
4. Identification and partial characterization of a Mr 105,000 nucleolar antigen associated with cell proliferation.
Chatterjee A; Freeman JW; Busch H
Cancer Res; 1987 Dec; 47(23):6329-34. PubMed ID: 3479243
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to human tumor nucleolar antigens: probes for studying biological function and determining clinical significance.
Freeman JW; Busch H
Hum Antibodies Hybridomas; 1991 Jan; 2(1):4-10. PubMed ID: 1873497
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines.
Kaplinsky C; Estrov Z; Freedman MH; Cohen A
Blood Cells; 1986; 11(3):459-68. PubMed ID: 3461855
[TBL] [Abstract][Full Text] [Related]
7. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
8. Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentiation of HL-60 leukemia cells.
Leung MF; Sokoloski JA; Sartorelli AC
Cancer Res; 1992 Feb; 52(4):949-54. PubMed ID: 1737356
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
[TBL] [Abstract][Full Text] [Related]
10. Intranucleolar localization of human proliferating cell nucleolar antigen p120.
Ochs RL; Reilly MT; Freeman JW; Busch H
Cancer Res; 1988 Nov; 48(22):6523-9. PubMed ID: 3052805
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
12. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
13. [Studies on changes in nucleolar organizer region of human promyelocytic leukemia cells (HL-60) treated with retinoic acid].
Xie RL; Wang YQ
Shi Yan Sheng Wu Xue Bao; 1989 Dec; 22(4):467-75. PubMed ID: 2626898
[TBL] [Abstract][Full Text] [Related]
14. Optimal loading of scraped HeLa cells with monoclonal antibodies to the proliferation-associated Mr 120,000 nucleolar antigen.
Freeman JW; Hazlewood JE; Auerbach P; Busch H
Cancer Res; 1988 Sep; 48(18):5246-50. PubMed ID: 3044583
[TBL] [Abstract][Full Text] [Related]
15. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
17. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
Keoffler HP; Yen J; Carlson J
J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
[TBL] [Abstract][Full Text] [Related]
18. Changes observed in the growth fraction, labeling index, duration of S phase, and total cell cycle times of HL-60 cells as they undergo differentiation in response to retinoic acid.
Gezer S; Yasin Z; Imren S; Freeman J; Black A; Raza A
Cancer Res; 1988 Nov; 48(21):5989-94. PubMed ID: 2844395
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
Maliszewski CR; Ball ED; Graziano RF; Fanger MW
J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
